KN Lazaridis, GJ Gores, KD Lindor - Journal of hepatology, 2001 - Elsevier In 1902, Hammarsten first reported the presence of an unknown bile acid in the
bile of the polar bear that he called 'ursocholeinic acid' [2]. At that time,
given the lack of knowledge on steroid compounds, Hammarsten was unable to ... Cited by 169 - Related articles - BL Direct - All 7 versions
K Kitani, M Ohta, S Kanai - American Journal of Physiology- Gastrointestinal and …, 1985 - Am Physiological Soc IT IS WELL KNOWN that most bile salts have dual effects on bile formation, one
choleretic and the other choles- tatic (8, 13). Even an efficient choleretic
such as tauro- cholate causes cholestasis when large amounts are given (8, ... Cited by 89 - Related articles - All 3 versions
ML Shiffman, GD Kaplan, V Brinkman-Kaplan … - Annals of internal medicine, 1995 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To determine whether prophylactic treatment with ursodeoxycholic ... Cited by 77 - Related articles - BL Direct - All 7 versions
S Tomida, M Abei, T Yamaguchi, Y Matsuzaki … - Hepatology, 1999 - journals.pasteur.ac.ir Whether ursodeoxycholic acid (UDCA) therapy alters the long-term clinical course
of gallstones (GS) without stone dissolution remains unknown. We aimed to
clarify the relationship between long-term UDCA therapy and risks of ... Cited by 68 - Related articles - BL Direct - All 4 versions
S Erlinger, A Le Go, JM Husson, J Fevery - Hepatology, 1984 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 60 - Related articles - All 4 versions
- ►annals.org RA Rubin, TE Kowalski, M Khandelwal, PF … - Annals of internal medicine, 1994 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Purpose: To explain the rationale supporting the use of ursodiol ( ... Cited by 53 - Related articles - All 3 versions
P Angulo, ER Dickson, TM Therneau, RA … - Journal of hepatology, 1999 - Elsevier Background/Aim: Ursodeoxycholic acid in doses of 13–15 mg·kg −1 ·day −1
, is a safe and cost-effective treatment for patients with primary biliary
cirrhosis. However, very limited information exists regarding the most ... Cited by 54 - Related articles - BL Direct - All 7 versions
K Miller, E Hell, B Lang, E Lengauer - Annals of surgery, 2003 - pubmedcentral.nih.gov Patients with vertical banded gastroplasty (VBG) and adjustable gastric banding
(AGB) were enrolled in this study. A single-center, randomized, double-blind,
prospective trial evaluated 500 mg of ursodeoxycholic acid versus placebo, ... Cited by 44 - Related articles - BL Direct - All 5 versions
P Angulo - Current Gastroenterology Reports, 2002 - Springer Introduction The earliest use of ursodeoxycholic acid (UDCA) in the treatment of
liver disease dates several centuries back to ancient Chinese folk medicine.
However, it was after Iwasaki [1] defined the chemical structure of UDCA in ... Cited by 40 - Related articles - BL Direct - All 2 versions
R Roehrkasse, H Fromm, M Malavolti, AK … - Digestive Diseases and Sciences, 1986 - Springer Sixteen patients with radiolucent gallstones were treated with a combination of
chenodeoxycholic and ursodeoxycholic acids for an average of 19 months. Liver
tests remained normal in all patients. In nine of 15 patients (60%), in ... Cited by 38 - Related articles - All 3 versions
